198 related articles for article (PubMed ID: 32171711)
1. Regulatory needs and activities to address the retinoid system in the context of endocrine disruption: The European viewpoint.
Grignard E; Håkansson H; Munn S
Reprod Toxicol; 2020 Apr; 93():250-258. PubMed ID: 32171711
[TBL] [Abstract][Full Text] [Related]
2. Fifteen years after "Wingspread"--environmental endocrine disrupters and human and wildlife health: where we are today and where we need to go.
Hotchkiss AK; Rider CV; Blystone CR; Wilson VS; Hartig PC; Ankley GT; Foster PM; Gray CL; Gray LE
Toxicol Sci; 2008 Oct; 105(2):235-59. PubMed ID: 18281716
[TBL] [Abstract][Full Text] [Related]
3. Emerging concepts and opportunities for endocrine disruptor screening of the non-EATS modalities.
Martyniuk CJ; Martínez R; Navarro-Martín L; Kamstra JH; Schwendt A; Reynaud S; Chalifour L
Environ Res; 2022 Mar; 204(Pt A):111904. PubMed ID: 34418449
[TBL] [Abstract][Full Text] [Related]
4. OECD approaches and considerations for regulatory evaluation of endocrine disruptors.
Browne P; Van Der Wal L; Gourmelon A
Mol Cell Endocrinol; 2020 Mar; 504():110675. PubMed ID: 31830512
[TBL] [Abstract][Full Text] [Related]
5. Endocrine Disruption: Current approaches for regulatory testing and assessment of plant protection products are fit for purpose.
Day P; Green RM; Gross M; Weltje L; Wheeler JR
Toxicol Lett; 2018 Oct; 296():10-22. PubMed ID: 30006252
[TBL] [Abstract][Full Text] [Related]
6. Risk assessment of endocrine active chemicals: identifying chemicals of regulatory concern.
Bars R; Fegert I; Gross M; Lewis D; Weltje L; Weyers A; Wheeler JR; Galay-Burgos M
Regul Toxicol Pharmacol; 2012 Oct; 64(1):143-54. PubMed ID: 22735369
[TBL] [Abstract][Full Text] [Related]
7. ERGO: Breaking Down the Wall between Human Health and Environmental Testing of Endocrine Disrupters.
Holbech H; Matthiessen P; Hansen M; Schüürmann G; Knapen D; Reuver M; Flamant F; Sachs L; Kloas W; Hilscherova K; Leonard M; Arning J; Strauss V; Iguchi T; Baumann L
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331419
[TBL] [Abstract][Full Text] [Related]
8. Development of a data-driven approach to Adverse Outcome Pathway network generation: a case study on the EATS-modalities.
Wiklund L; Caccia S; Pípal M; Nymark P; Beronius A
Front Toxicol; 2023; 5():1183824. PubMed ID: 37229356
[TBL] [Abstract][Full Text] [Related]
9. Expression variations of two retinoid signaling pathway receptors in the rotifer Brachionus calyciflorus exposed to three endocrine disruptors.
Joaquim-Justo C; Gismondi E
Ecotoxicology; 2021 Mar; 30(2):343-350. PubMed ID: 33443716
[TBL] [Abstract][Full Text] [Related]
10. The retinoic acid receptor (RAR) in molluscs: Function, evolution and endocrine disruption insights.
André A; Ruivo R; Fonseca E; Froufe E; Castro LFC; Santos MM
Aquat Toxicol; 2019 Mar; 208():80-89. PubMed ID: 30639747
[TBL] [Abstract][Full Text] [Related]
11. An approach to the identification and regulation of endocrine disrupting pesticides.
Ewence A; Brescia S; Johnson I; Rumsby PC
Food Chem Toxicol; 2015 Apr; 78():214-20. PubMed ID: 25666658
[TBL] [Abstract][Full Text] [Related]
12. Science based guidance for the assessment of endocrine disrupting properties of chemicals.
Bars R; Broeckaert F; Fegert I; Gross M; Hallmark N; Kedwards T; Lewis D; O'Hagan S; Panter GH; Weltje L; Weyers A; Wheeler JR; Galay-Burgos M
Regul Toxicol Pharmacol; 2011 Feb; 59(1):37-46. PubMed ID: 20858523
[TBL] [Abstract][Full Text] [Related]
13. Critical Review of Read-Across Potential in Testing for Endocrine-Related Effects in Vertebrate Ecological Receptors.
McArdle ME; Freeman EL; Staveley JP; Ortego LS; Coady KK; Weltje L; Weyers A; Wheeler JR; Bone AJ
Environ Toxicol Chem; 2020 Apr; 39(4):739-753. PubMed ID: 32030793
[TBL] [Abstract][Full Text] [Related]
14. Towards a science-based testing strategy to identify maternal thyroid hormone imbalance and neurodevelopmental effects in the progeny - Part IV: the ECETOC and CLE Proposal for a Thyroid Function-Related Neurodevelopmental Toxicity Testing and Assessment Scheme (Thyroid-NDT-TAS).
Melching-Kollmuss S; Bothe K; Charlton A; Gangadharan B; Ghaffari R; Jacobi S; Marty S; Marxfeld HA; McInnes EF; Sauer UG; Sheets LP; Strupp C; Tinwell H; Wiemann C; Botham PA; van Ravenzwaay B
Crit Rev Toxicol; 2023 Jul; 53(6):339-371. PubMed ID: 37554099
[TBL] [Abstract][Full Text] [Related]
15. Signal transduction by retinoid receptors.
Pfahl M
Skin Pharmacol; 1993; 6 Suppl 1():8-16. PubMed ID: 8142116
[TBL] [Abstract][Full Text] [Related]
16. Endocrine disruptors and reproductive development: a weight-of-evidence overview.
Cooper RL; Kavlock RJ
J Endocrinol; 1997 Feb; 152(2):159-66. PubMed ID: 9071972
[TBL] [Abstract][Full Text] [Related]
17. Effects of novel retinoid X receptor-selective ligands on myeloid leukemia differentiation and proliferation in vitro.
Kizaki M; Dawson MI; Heyman R; Elster E; Morosetti R; Pakkala S; Chen DL; Ueno H; Chao W; Morikawa M; Ikeda Y; Heber D; Pfahl M; Koeffler HP
Blood; 1996 Mar; 87(5):1977-84. PubMed ID: 8634447
[TBL] [Abstract][Full Text] [Related]
18. Retinoid metabolism in invertebrates: when evolution meets endocrine disruption.
André A; Ruivo R; Gesto M; Castro LF; Santos MM
Gen Comp Endocrinol; 2014 Nov; 208():134-45. PubMed ID: 25132059
[TBL] [Abstract][Full Text] [Related]
19. Environmental effect assessment for sexual endocrine-disrupting chemicals: Fish testing strategy.
Knacker T; Boettcher M; Frische T; Rufli H; Stolzenberg HC; Teigeler M; Zok S; Braunbeck T; Schäfers C
Integr Environ Assess Manag; 2010 Oct; 6(4):653-62. PubMed ID: 20872646
[TBL] [Abstract][Full Text] [Related]
20. Hypothesis-driven weight-of-evidence analysis of endocrine disruption potential: a case study with triclosan.
Mihaich E; Capdevielle M; Urbach-Ross D; Slezak B
Crit Rev Toxicol; 2017 Apr; 47(4):263-285. PubMed ID: 28128023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
